Scientists are hoping that heat therapy could eventually replace a complex drug regimen as the first-line treatment of a parasitic skin infection common in tropical and subtropical regions of the world. The…
Tag: virus
Needleless IV Connectors Connected To Bloodstream Infections
Improvement of a small, inexpensive disposable device could be the key to preventing hospital-acquired bloodstream infections, says a nurse researcher at Georgia Health Sciences University (formerly the Medical College of Georgia). Dr….
AHRQ: $25.3 billion spent for kidney disease treatment every year
Overall, an average of 3.7 million adults in the United States were treated for kidney disease each year between 2003 and 2007, according to the latest News and Numbers from the Agency…
Vaccinating through salivary glands may provide protection against wide range of diseases
If you don’t like shots or needles, you’re in luck. New research published online in The FASEB Journal (https://www.fasebj.org) gives the development of new oral vaccinations a shot in the arm thanks…
Protective immunity against HIV can be achieved without presence of virus neutralizing antibodies in the blood
New research shows that protective immunity against HIV can be achieved without the presence of virus neutralizing antibodies in the blood. The study, published by Cell Press in the February issue of…
Silver treated IV connectors may cause potentially deadly infections
Nationally-acclaimed researcher and award-winning author Dr. Cynthia C. Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly…
FDA grants Inhibitex Fast Track Designation for INX-189 in treatment of chronic hepatitis C viral infection
Inhibitex, Inc. (Nasdaq: INHX) today reported that the U.S. Food and Drug Administration (“FDA”) has designated the investigation of INX-08189 (“INX-189”), a potent guanosine nucleotide polymerase inhibitor for the treatment of chronic…
Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease
Novel therapeutic approach regulates all fibrotic pathologies driven by TGF-beta1, a major mediator of idiopathic pulmonary fibrosis. Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory…
Anacor, Medicis collaborate to discover and develop boron-based treatment for acne
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) and Medicis Pharmaceutical Corporation (NYSE:MRX) today announced that the two companies have entered into a research and development agreement to discover and develop boron-based small molecule compounds directed…
Medivir initiates phase 1a clinical trial of TMC649128 for chronic HCV infection
Medivir AB (OMX: MVIR), the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces the start of a phase 1a clinical trial with TMC649128 intended for the treatment of chronic…
Global Health Consortium to support development of vaccines to control dengue fever
Global Health Consortium will raise the profile of dengue and promote prevention through vaccination The International Vaccine Institute (IVI) today announced the launch of the Dengue Vaccine Initiative (DVI), in collaboration with…
A sneeze can contaminate a room for hours
A single sneeze infests a room with deadly bugs and the contamination can last for hours. Microscopic droplets sneezed or coughed out float around the air in large enough concentrations to spread…
Key advance in development of fast, simple test for detection of cholera
With cholera on the rampage in Haiti and almost 40 other countries, scientists are reporting the development of a key advance that could provide a fast, simple test to detect the toxin…
Three simple steps to keep your family protected against infections
The Global Hygiene Council, a group of leading health and hygiene experts from around the world, convened in collaboration with the Centers for Disease Control and Prevention (CDC) to discuss how proper…
Liquidia to explore PRINT particle technology with PATH Malaria Vaccine Initiative
Liquidia Technologies today announced a collaboration with the PATH Malaria Vaccine Initiative (MVI) to explore the use of the company’s PRINT® particle technology to design next generation malaria vaccines. PRINT technology offers…